Literature DB >> 29790037

One-year optical coherence tomography findings in patients with late and very-late stent thrombosis treated with intravascular imaging guided percutaneous coronary intervention.

Marcos Ñato1,2,3, Josep Gomez-Lara4,5,6, Rafael Romaguera1,2,3, Gerard Roura1,2,3, José Luis Ferreiro1,2,3, Luis Teruel1,2,3, Montserrat Gracida1,2,3, Lara Fuentes1,2,3, Bert Vandeloo1,2,3, Joan-Antoni Gomez-Hospital1,2,3, Angel Cequier1,2,3.   

Abstract

Patients with late/very-late stent thrombosis (ST) are at high risk of recurrent-ST. The mechanisms of recurrent-ST are largely unknown. The objective is to describe the 1-year optical coherence tomography (OCT) findings of patients suffering from late/very-late ST treated with intravascular imaging guided percutaneous coronary intervention (PCI). All consecutive patients with late/very-late ST undergoing intravascular imaging guided PCI were screened to undergo coronary angiography and OCT examination at 1 year. Patients were classified according to the observation of stent malapposition as most contributing cause of the ST. Thirty-four patients were included. Stent malapposition was observed in 17 (50%) and the remaining 17 cases were classified as: neoatherosclerosis (n = 9), underexpansion (n = 3) and unknown mechanism (n = 5). Patients with malapposition had a remarkable reduction of the malapposition volume (from 6.4 to 1.3 mm3; p = 0.02) during the ST procedure, but this was not fully corrected in 13 (76.5%). At 12 months, two patients of the malapposition group presented with uneventful target vessel re-occlusion. Persistent malapposition was observed in nine patients (60.0%). Major coronary evaginations (46.7 vs. 0%; p = 0.001) and uncovered struts (6.3 vs. 1.0%; p < 0.001) were also more frequent in patients with malapposition than without malapposition. None of the patients had thin-cap fibroatheroma neoatherosclerosis. Contributing causes of late/very-late ST are diverse and have different healing patterns at 12 months. Patients with stent malapposition treated with intravascular imaging guided PCI showed poor re-healing; but patients with other causes of the ST showed optimal stent healing as assessed by OCT.

Entities:  

Keywords:  Intravascular ultrasound (IVUS); Optical coherence tomography (OCT); Percutaneous coronary intervention (PCI); Stent thrombosis (ST)

Mesh:

Year:  2018        PMID: 29790037     DOI: 10.1007/s10554-018-1372-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  19 in total

1.  IVUS-guided treatment strategies for definite late and very late stent thrombosis.

Authors:  Josep Gomez-Lara; Neus Salvatella; Nieves Gonzalo; Felipe Hernández-Hernández; Eduard Fernandez-Nofrerias; Angel Sánchez-Recalde; Teresa Bastante; Ana Marcano; Rafael Romaguera; José-Luis Ferreiro; Gerard Roura; Luis Teruel; Albert Ariza-Solé; Faustino Miranda-Guardiola; Vera Rodríguez García-Abad; Joan-Antoni Gomez-Hospital; Fernando Alfonso; Angel Cequier
Journal:  EuroIntervention       Date:  2016-12-10       Impact factor: 6.534

2.  A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial).

Authors:  Robert J Russo; Patricia D Silva; Paul S Teirstein; Michael J Attubato; Charles J Davidson; Anthony C DeFranco; Peter J Fitzgerald; Steven L Goldberg; James B Hermiller; Martin B Leon; Frederick S Ling; Jennifer E Lucisano; Richard A Schatz; S Chiu Wong; Neil J Weissman; David M Zientek
Journal:  Circ Cardiovasc Interv       Date:  2009-02-20       Impact factor: 6.546

3.  Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.

Authors:  Kunihiro Shimamura; Takashi Kubo; Takashi Akasaka; Ken Kozuma; Kazuo Kimura; Masaki Kawamura; Tetsuya Sumiyoshi; Yasushi Ino; Minoru Yoshiyama; Shinjo Sonoda; Keiichi Igarashi; Akiyoshi Miyazawa; Hiroyasu Uzui; Yuji Sakanoue; Toshiro Shinke; Yoshihiro Morino; Kengo Tanabe; Kazushige Kadota; Takeshi Kimura
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10-23       Impact factor: 6.875

4.  Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.

Authors:  Tomohisa Tada; Robert A Byrne; Iva Simunovic; Lamin A King; Salvatore Cassese; Michael Joner; Massimiliano Fusaro; Simon Schneider; Stefanie Schulz; Tareq Ibrahim; Ilka Ott; Steffen Massberg; Karl-Ludwig Laugwitz; Adnan Kastrati
Journal:  JACC Cardiovasc Interv       Date:  2013-12       Impact factor: 11.195

5.  Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.

Authors:  Josep Gomez-Lara; Salvatore Brugaletta; Francisco Jacobi; Luis Ortega-Paz; Marcos Ñato; Gerard Roura; Rafael Romaguera; Jose-Luis Ferreiro; Luis Teruel; Montserrat Gracida; Victoria Martin-Yuste; Xavier Freixa; Monica Masotti; Joan-Antoni Gomez-Hospital; Manel Sabate; Angel Cequier
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

6.  Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.

Authors:  Giulio Guagliumi; Vasile Sirbu; Giuseppe Musumeci; Robert Gerber; Giuseppe Biondi-Zoccai; Hideyuki Ikejima; Elena Ladich; Nikoloz Lortkipanidze; Aleksandre Matiashvili; Orazio Valsecchi; Renu Virmani; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2012-01       Impact factor: 11.195

7.  Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.

Authors:  Kyohei Yamaji; Lorenz Räber; Thomas Zanchin; Ernest Spitzer; Christian Zanchin; Thomas Pilgrim; Stefan Stortecky; Aris Moschovitis; Michael Billinger; Christa Schönenberger; Franz Eberli; Peter Jüni; Thomas F Lüscher; Dik Heg; Stephan Windecker
Journal:  Eur Heart J       Date:  2016-08-30       Impact factor: 29.983

8.  Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis.

Authors:  Stephen W Waldo; Ehrin J Armstrong; Khung-Keong Yeo; Mitul Patel; Ryan Reeves; John S Macgregor; Reginald I Low; Ehtisham Mahmud; Jason H Rogers; Kendrick Shunk
Journal:  Catheter Cardiovasc Interv       Date:  2013-07-02       Impact factor: 2.692

9.  Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).

Authors:  José M de la Torre-Hernández; Fernando Alfonso; Felipe Hernández; Jaime Elizaga; Marcelo Sanmartin; Eduardo Pinar; Iñigo Lozano; Jose M Vazquez; Javier Botas; Armando Perez de Prado; Jose M Hernández; Juan Sanchis; Juan M Ruiz Nodar; Alfredo Gomez-Jaume; Mariano Larman; Jose A Diarte; Javier Rodríguez-Collado; Jose R Rumoroso; Jose R Lopez-Minguez; Josepa Mauri
Journal:  J Am Coll Cardiol       Date:  2008-03-11       Impact factor: 24.094

10.  Bare-metal stent thrombosis two decades after stenting.

Authors:  Aynur Acibuca; Demet Menekse Gerede; Veysel Kutay Vurgun
Journal:  Cardiovasc J Afr       Date:  2015-07-23       Impact factor: 1.167

View more
  1 in total

Review 1.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.